IGC Pharma, Inc. (IGC)

IGC Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 30, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	27	23	26	18	48	81
Market Cap Growth	5.51%	-14.06%	46.64%	-62.80%	-40.34%	321.48%
Enterprise Value	26	23	25	14	37	79
Last Close Price	0.28	0.28	0.40	0.34	0.95	1.79
Forward PE	-	4.35	4.35	4.35	4.35	4.35
PS Ratio	20.73	17.87	19.65	19.78	122.03	90.43
PB Ratio	3.15	3.59	3.61	1.21	2.03	2.48
P/TBV Ratio	8.27	5.07	4.63	1.31	2.11	2.51
PEG Ratio	-	2.26	2.26	2.26	2.26	2.26
EV/Sales Ratio	23.13	17.71	18.91	14.82	93.57	88.35
Debt / Equity Ratio	0.02	0.04	0.05	0.03	0.03	0.03
Asset Turnover	0.11	0.14	0.10	0.04	0.01	0.03
Inventory Turnover	0.55	0.45	0.29	0.15	0.04	0.14
Quick Ratio	0.79	0.21	0.55	1.83	4.53	6.27
Current Ratio	1.32	1.28	1.58	3.41	6.19	9.93
Return on Equity (ROE)	-83.34%	-104.33%	-116.95%	-59.30%	-52.97%	-29.70%
Return on Assets (ROA)	-50.31%	-49.91%	-45.23%	-32.86%	-29.10%	-16.81%
Return on Capital Employed (ROCE)	-98.40%	-114.70%	-129.60%	-75.70%	-59.80%	-26.00%
Earnings Yield	-24.26%	-31.36%	-49.20%	-63.85%	-31.00%	-10.85%
FCF Yield	-21.17%	-21.61%	-20.20%	-40.83%	-15.89%	-15.11%
Buyback Yield / Dilution	-19.49%	-30.04%	-11.91%	-5.17%	-19.13%	-6.26%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q